1. Home
  2. MGIC vs INM Comparison

MGIC vs INM Comparison

Compare MGIC & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Magic Software Enterprises Ltd.

MGIC

Magic Software Enterprises Ltd.

HOLD

Current Price

$26.25

Market Cap

990.3M

Sector

Technology

ML Signal

HOLD

Logo InMed Pharmaceuticals Inc.

INM

InMed Pharmaceuticals Inc.

HOLD

Current Price

$1.22

Market Cap

3.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MGIC
INM
Founded
1983
1981
Country
Israel
Canada
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
990.3M
3.7M
IPO Year
1991
N/A

Fundamental Metrics

Financial Performance
Metric
MGIC
INM
Price
$26.25
$1.22
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$18.00
N/A
AVG Volume (30 Days)
44.7K
145.5K
Earning Date
11-18-2025
02-11-2026
Dividend Yield
2.24%
N/A
EPS Growth
16.15
N/A
EPS
0.81
N/A
Revenue
$603,216,000.00
$4,798,116.00
Revenue This Year
$12.87
N/A
Revenue Next Year
$6.23
N/A
P/E Ratio
$33.24
N/A
Revenue Growth
12.65
N/A
52 Week Low
$11.36
$1.13
52 Week High
$27.44
$8.27

Technical Indicators

Market Signals
Indicator
MGIC
INM
Relative Strength Index (RSI) 58.17 40.93
Support Level $24.52 $1.18
Resistance Level $27.17 $1.35
Average True Range (ATR) 0.75 0.10
MACD -0.08 0.01
Stochastic Oscillator 65.58 17.19

Price Performance

Historical Comparison
MGIC
INM

About MGIC Magic Software Enterprises Ltd.

Magic Software Enterprises Ltd is a software development company. The company's operating segment includes Software Services and IT Professional Services. The company generates maximum revenue from the IT Professional Services segment. IT Professional Services segment offers IT services in the areas of infrastructure design and delivery, application development, technology planning and implementation services, communications services and solutions, as well as supplemental outsourcing services. Geographically, it derives a majority of revenue from the United States and also has a presence in Israel, Europe, Japan, and Other countries.

About INM InMed Pharmaceuticals Inc.

InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The Company's operations consist of two operating and reportable segments, the InMed Pharma segment and the BayMedica Commercial segment. The InMed Pharma segment is largely organized around the research and development of small molecule pharmaceuticals drug candidates and the BayMedica Commercial segment is largely organized around manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease.

Share on Social Networks: